A marked decrease of neutrophil alkaline phosphatase (NAP) has been found in a 22-year-old pregnant woman with AIDS. The newborn (2.280 kg, week 36) was affected by encephalopathy and anoxic status and died 23 days after delivery. The laboratory findings, obtained at week 33 of pregnancy, showed specific anti-HIVi antibodies as determined by ELISA, a reduced number of OKT4 cells with low OKT4/T8 ratio, and an anti-D antibody (Coombs 1/16, IgG3). Using biochemical [1] and cytochemical [2] techniques, the NAP activity was determined in the patient and in control pregnant women. This study was completed by additional biological tests, performed in nonpregnant AIDS patients and controls (tables I-III). The pregnant patient with AIDS had a marked decrease of NAP activity and a drop in thermostable AP, following 1.5 min microwave (2,050 MHz; P = 0.45 kW, 220 V 50 Hz, 4.4 Am) or 56 °C for 10 min. In AIDS cases without pregnancy we observed an increase in NAP activity and a high residual fraction of thermostable NAP. These results suggest: (1) the presence of a thermo-labile AP variant in PMN of pregnant women with AIDS; (2) this nonspecific NAP seems to correlate with a clinical evolution: 6 months postpartum, the Table I . Cytochemical study of NAP and microwave NAP in a patient with AIDS and in control women NAP activity scores Microwave NAP scores patient presented a critical status and (3) the nonpregnant women with AIDS and with high NAP activity were clinically stable between 11 and 25 months. Table II . NAP biochemical assay and thermostability measured in the AIDS case and in normal controls NAP activity nmol/h/106cell 0 25 ± 5
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